David A. Siegel Decibel Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.83 - $5.03 $31,979 - $56,839	-11,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.57 - $8.58 $51,641 - $96,954	11,300 New	11,300 $53,000
Q2 2021 Aug 16, 2021	SELL	$6.39 - $11.51 $96,489 - $173,801	-15,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.56 - $19.9 $159,456 - $300,490	15,100 New	15,100 $172,000

Ticker DBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,964,500
Description
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.